Glucagon's effect on kidney blood flow using MRI
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study uses a special MRI scan to see how a hormone called glucagon affects blood flow in your kidneys. Healthy volunteers will help researchers understand how the kidneys work, which may lead to better treatments for kidney disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be in generally good health, confirmed by a doctor and basic tests
- You can't have taken immune-lowering medications in the past year
- You can't have a history of alcohol abuse
- You can't be taking certain medications that affect blood sugar or blood pressure (like steroids, diabetes drugs, or lithium)
- You must not have liver or kidney disease, high blood pressure, or claustrophobia
- You must have no metal or electronic devices in your body that can't go in an MRI
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how the hormone glucagon affects kidney function in healthy men. It may help researchers understand how glucagon works in the body.
This study looks at how SGLT2 inhibitors (a type of diabetes medication) protect the kidneys in people with type 2 diabetes and kidney disease. It may help explain why these drugs are beneficial for kidney health.
This study looks at how the liver handles insulin and glucagon, two hormones that control blood sugar. It is for healthy adults to help researchers understand normal liver function.
This study looks at how isometric exercise (like planks or wall sits) affects your heart and kidneys, using advanced scans (PET/CT and MRI). It's for healthy people to understand the normal effects of exercise on these organs.
This study tests whether a substance measured from blood and MRI signals can predict how your body fights low blood sugar. It’s done in healthy adults to see if the marker could help in future low-blood-sugar risk tracking.
This trial tests if canagliflozin, a diabetes medication, can help people with very advanced kidney disease or who recently started dialysis. It uses MRI scans to see how the drug affects the heart and kidneys.
Hear when a new Kidney Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.